Search results
Short bouts of exercise may boost efficacy of some types of cancer treatment
MedicalNewsToday via AOL· 1 day agoRecent research suggests that short bouts of moderate to intense exercise could boost the efficacy...
Fauci Grilled by Lawmakers on Masks, Vaccine Mandates and Lab Leak Theory
New York Times· 4 days agoDr. Fauci testified before a House panel investigating Covid’s origins. Dr. Anthony S. Fauci, the...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 7 days agoInvivyd Inc. (NASDAQ: IVVD), a biopharmaceutical company, has announced an agreement with the U.S....
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 3 days agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial...
Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024
Benzinga· 8 hours agoJINAN, China, June 6, 2024 /PRNewswire/ -- The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened from May 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works,
Arrivent Biopharma enters into cancer drug development collaboration valued at up to $615M -...
The Business Journals· 2 days agoAntibody drug conjugates, or ADCs, are a type of cancer treatment that combines a monoclonal ...
Stocks making the biggest moves before the bell: Robinhood, Nvidia, Lululemon, Five Below and more
CNBC· 1 day agoThe online brokerage rose more than 3% after revealing a $200 million deal to purchase crypto...
S2 Episode 3: How Do You Treat Refractory Colorectal Cancer?
Medscape· 2 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
The Woonsocket Call· 4 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on June 1, 2024 the Company granted ...